Skip to content
MedsAcross

Brand family

Ogsiveo

Nirogacestat · SpringWorks Therapeutics
United States
Presentations
2
Markets
1

Ogsiveo is a brand of Nirogacestat marketed by SpringWorks Therapeutics, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Nirogacestat
Brand owner
SpringWorks Therapeutics
Registered in
United States
Strengths and forms
100 mg tablet, 150 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Ogsiveo 100 mg tabletOralSpringWorks TherapeuticsUS FDAAvailable on request
Ogsiveo 150 mg tabletOralSpringWorks TherapeuticsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Ogsiveo

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.